Education

B.S., Biomedical Engineering, 2014, Johns Hopkins University
M.S., Biomedical Engineering, 2021, Columbia University
Ph.D., Biomedical Engineering, 2025 (expected), Columbia University

Curriculum vitae

Areas of Research Interest

Tissue engineering, regenerative medicine, osteoarthritis

Background

Matt began his research career in the laboratory of Dr. Garry Cutting at the Johns Hopkins University where he studied ion transport and drug response in an in vitro cystic fibrosis model. From there, he joined the Research and Exploratory Development Department at the Johns Hopkins Applied Physics Laboratory (APL). At APL, he developed materials and methods for 3D-bioprinting of tissue-engineered skin, along with image processing and analysis methods.

Matt joined the Cellular Engineering Lab in 2019 and has focused on developing novel methods for cartilage tissue engineering and non-standard mechanical testing of engineered and ex vivo tissues. He is particularly interested in developing multidisciplinary approaches that incorporate both traditional and novel tissue engineering methodologies for functional tissue engineering and regenerative medicine.

Outside of the lab, Matt enjoys playing soccer, managing his several (very successful) fantasy football teams, and cooking.

Selected Publications

1. Han ST, Rab A, Pellicore MJ, Davis E, McCague AF, Evans TA, Joynt AT, Lu Z, Cai Z, Raraigh KS, Hong J, Sheppard DN, Sorscher EJ, Cutting GR. Residual function of cystic fibrosis mutants predicts response to small molecule CFTR correctors. JCI Insight. 2018;3(14) [epub ahead of print].

2. Raraigh KS, Han ST, Davis E, Evans TA, Pellicore MJ, McCague AF, Joynt AT, Lu Z, Atalar M, Sharma N, Sheridan MB, Sosnay PR, Cutting GR. Functional assays are essential for the interpretation of missense variants associated with variable expressivity. The American Journal of Human Genetics 2018;102(6):1062-1077.

3. Sharma N, Evans TA, Pellicore MJ, Davis E, Aksit M, McCague A, Joynt A, Lu Z, Han ST, Anzmann AL, Lam A, Thaxton A, West N, Merlo C, Gottschalk LB, Raraigh K, Sosnay PR, Cotton C, and Cutting GR. Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis. PLOS Genetics 2018; in press.